{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hallandale Beach",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80699",
      "recalling_firm": "Pharmcore Inc.",
      "address_1": "1109 E Hallandale Beach Blvd",
      "address_2": "N/A",
      "postal_code": "33009-4431",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1153-2018",
      "product_description": "Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009",
      "product_quantity": "6 vials",
      "reason_for_recall": "Lack of assurance of sterility.",
      "recall_initiation_date": "20180802",
      "center_classification_date": "20180828",
      "termination_date": "20220118",
      "report_date": "20180905",
      "code_info": "Lot: IPA3-17 Exp. 07/2018"
    }
  ]
}